Managed Account Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-23,762
Closed -$2.32M 3205
2015
Q1
$2.32M Buy
+23,762
New +$2.32M ﹤0.01% 1781
2014
Q4
Sell
-3,852
Closed -$265K 2827
2014
Q3
$265K Sell
3,852
-12,807
-77% -$881K ﹤0.01% 2279
2014
Q2
$1.75M Sell
16,659
-5,629
-25% -$590K ﹤0.01% 1827
2014
Q1
$1.85M Buy
22,288
+13,245
+146% +$1.1M ﹤0.01% 1764
2013
Q4
$585K Sell
9,043
-530
-6% -$34.3K ﹤0.01% 2034
2013
Q3
$607K Sell
9,573
-8,434
-47% -$535K ﹤0.01% 1979
2013
Q2
$756K Buy
+18,007
New +$756K ﹤0.01% 1929